Understanding how a specific protein protects the brain from degeneration
Dissecting the neuroprotective role of an RNA binding protein in neurodegeneration
This study is looking at how certain proteins in our cells can help protect the brain from Alzheimer's disease, with the hope of finding new treatments that could help people affected by this condition.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pennsylvania State University, the NIH-funded |
| Lab location | 1 site (University Park, United States) |
| Project ID | NIH-11143486 on NIH RePORTER |
What this research studies
This research investigates the role of RNA binding proteins in protecting the brain from neurodegenerative diseases, particularly Alzheimer's disease. It aims to uncover how these proteins influence the accumulation of harmful amyloid proteins that are associated with cognitive decline. By studying the molecular mechanisms of these proteins, the research seeks to identify potential new treatments that could prevent or mitigate brain damage in affected individuals. Patients may benefit from insights that could lead to innovative therapies targeting neurodegeneration.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 65 and older who are at risk for or experiencing symptoms of Alzheimer's disease.
Not a fit: Patients under the age of 65 or those with non-neurodegenerative conditions may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that prevent or slow down the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in targeting amyloid proteins for Alzheimer's treatment, indicating that this approach may yield valuable insights.
Where this research is happening
University Park, United States
- Pennsylvania State University, the — University Park, United States (Active)
Researchers
- Principal investigator: Mao, Yingwei — Pennsylvania State University, the
- Study coordinator: Mao, Yingwei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.